carbamazepine has been researched along with glycolipids in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atzpodien, W; Bierbach, H; Denk, R; Haferkamp, G; Kremer, GJ; Schnellbacher, E | 1 |
Atzpodien, W; Kremer, GJ | 1 |
Goto, I; Inoue, N; Kuroiwa, Y; Shibasaki, H; Tabira, T | 2 |
Goldberg, MA; Todoroff, T | 1 |
Holsboer, F; Perisic, T; Rein, T; Yu, S; Zimmermann, N; Zschocke, J | 1 |
1 trial(s) available for carbamazepine and glycolipids
Article | Year |
---|---|
Carbamazepine for painful crises in Fabry's disease.
Topics: Adult; Carbamazepine; Clinical Trials as Topic; Evaluation Studies as Topic; Glycolipids; Humans; Kidney Diseases; Lipid Metabolism, Inborn Errors; Male; Placebos | 1973 |
5 other study(ies) available for carbamazepine and glycolipids
Article | Year |
---|---|
[Angiokeratoma corporis diffusum (Fabry's disease). Biochemical diagnosis in plasma].
Topics: Adult; Carbamazepine; Electrocardiography; Fabry Disease; Galactosidases; Glycolipids; Heterozygote; Humans; Male; Phenytoin | 1975 |
[Fabry's diffuse angiokeratoma corporis].
Topics: Age Factors; Carbamazepine; Fabry Disease; Galactosidases; Glycolipids; Heterozygote; Humans; Kidney Failure, Chronic; Kidney Transplantation; Phenytoin; Sex Factors; Sphingolipids | 1975 |
[Fabry's disease--case report and treatment of painful crises by carbamazepine].
Topics: Adult; Carbamazepine; Glycolipids; Humans; Japan; Lipid Metabolism, Inborn Errors; Male; Pain; Pedigree; Syndrome | 1973 |
Brain binding of anticonvulsants: carbamazepine and valproic acid.
Topics: Animals; Autoradiography; Brain; Carbamazepine; Chromatography, Thin Layer; In Vitro Techniques; Lipid Metabolism; Mice; Nerve Tissue Proteins; Phosphatidylethanolamines; Phosphatidylserines; Protein Binding; Rabbits; Sphingomyelins; Ultrafiltration; Valproic Acid | 1980 |
Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels.
Topics: Animals; Antidepressive Agents; Astrocytes; Carbamazepine; Cells, Cultured; Cerebral Cortex; Citalopram; Cyclohexanols; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Glycolipids; Histone-Lysine N-Methyltransferase; Imipramine; Indoles; Maleimides; Mice; Nerve Tissue Proteins; Neural Stem Cells; Neurons; Paroxetine; Protein Interaction Mapping; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Venlafaxine Hydrochloride | 2012 |